227 related articles for article (PubMed ID: 31345388)
1. The prognostic value of CT-based image-biomarkers for head and neck cancer patients treated with definitive (chemo-)radiation.
Zhai TT; Langendijk JA; van Dijk LV; Halmos GB; Witjes MJH; Oosting SF; Noordzij W; Sijtsema NM; Steenbakkers RJHM
Oral Oncol; 2019 Aug; 95():178-186. PubMed ID: 31345388
[TBL] [Abstract][Full Text] [Related]
2. Improving the prediction of overall survival for head and neck cancer patients using image biomarkers in combination with clinical parameters.
Zhai TT; van Dijk LV; Huang BT; Lin ZX; Ribeiro CO; Brouwer CL; Oosting SF; Halmos GB; Witjes MJH; Langendijk JA; Steenbakkers RJHM; Sijtsema NM
Radiother Oncol; 2017 Aug; 124(2):256-262. PubMed ID: 28764926
[TBL] [Abstract][Full Text] [Related]
3. Can FDG PET predict radiation treatment outcome in head and neck cancer? Results of a prospective study.
Schinagl DA; Span PN; Oyen WJ; Kaanders JH
Eur J Nucl Med Mol Imaging; 2011 Aug; 38(8):1449-58. PubMed ID: 21461734
[TBL] [Abstract][Full Text] [Related]
4. Imaging biomarkers of contrast-enhanced computed tomography predict survival in oesophageal cancer after definitive concurrent chemoradiotherapy.
Zeng C; Zhai T; Chen J; Guo L; Huang B; Guo H; Liu G; Zhuang T; Liu W; Luo T; Wu Y; Peng G; Li D; Chen C
Radiat Oncol; 2021 Jan; 16(1):8. PubMed ID: 33436018
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma.
Cacicedo J; Fernandez I; Del Hoyo O; Navarro A; Gomez-Iturriaga A; Pijoan JI; Martinez-Indart L; Escudero J; Gomez-Suarez J; de Zarate RO; Perez JF; Bilbao P; Rades D
Clin Transl Oncol; 2017 Nov; 19(11):1337-1349. PubMed ID: 28540535
[TBL] [Abstract][Full Text] [Related]
6. Predicting acute radiation induced xerostomia in head and neck Cancer using MR and CT Radiomics of parotid and submandibular glands.
Sheikh K; Lee SH; Cheng Z; Lakshminarayanan P; Peng L; Han P; McNutt TR; Quon H; Lee J
Radiat Oncol; 2019 Jul; 14(1):131. PubMed ID: 31358029
[TBL] [Abstract][Full Text] [Related]
7. Computed Tomography Radiomics Predicts HPV Status and Local Tumor Control After Definitive Radiochemotherapy in Head and Neck Squamous Cell Carcinoma.
Bogowicz M; Riesterer O; Ikenberg K; Stieb S; Moch H; Studer G; Guckenberger M; Tanadini-Lang S
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):921-928. PubMed ID: 28807534
[TBL] [Abstract][Full Text] [Related]
8. Comparison of PET and CT radiomics for prediction of local tumor control in head and neck squamous cell carcinoma.
Bogowicz M; Riesterer O; Stark LS; Studer G; Unkelbach J; Guckenberger M; Tanadini-Lang S
Acta Oncol; 2017 Nov; 56(11):1531-1536. PubMed ID: 28820287
[TBL] [Abstract][Full Text] [Related]
9. Primary tumor volume is an important predictor of clinical outcomes among patients with locally advanced squamous cell cancer of the head and neck treated with definitive chemoradiotherapy.
Strongin A; Yovino S; Taylor R; Wolf J; Cullen K; Zimrin A; Strome S; Regine W; Suntharalingam M
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1823-30. PubMed ID: 21549516
[TBL] [Abstract][Full Text] [Related]
10. Combined CT radiomics of primary tumor and metastatic lymph nodes improves prediction of loco-regional control in head and neck cancer.
Bogowicz M; Tanadini-Lang S; Guckenberger M; Riesterer O
Sci Rep; 2019 Oct; 9(1):15198. PubMed ID: 31645603
[TBL] [Abstract][Full Text] [Related]
11. Computed tomography-derived radiomic signature of head and neck squamous cell carcinoma (peri)tumoral tissue for the prediction of locoregional recurrence and distant metastasis after concurrent chemo-radiotherapy.
Keek S; Sanduleanu S; Wesseling F; de Roest R; van den Brekel M; van der Heijden M; Vens C; Giuseppina C; Licitra L; Scheckenbach K; Vergeer M; Leemans CR; Brakenhoff RH; Nauta I; Cavalieri S; Woodruff HC; Poli T; Leijenaar R; Hoebers F; Lambin P
PLoS One; 2020; 15(5):e0232639. PubMed ID: 32442178
[TBL] [Abstract][Full Text] [Related]
12. [Outcome and prognostic factors of 125 loco-regionally advanced head and neck squamous cell carcinoma treated with multi-modality treatment].
Qian W; Zhu G; Ji Q; Guo Y; Wang Y; Wang Y
Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):217-22. PubMed ID: 24785284
[TBL] [Abstract][Full Text] [Related]
13. Correlation of Computerized Tomography density patterns of lymph nodes with treatment results and outcome in head and neck cancer patients treated by 2 different chemoradiotherapy schedules.
Jaju S; Gupta SK; Pandey S; Singh V
J Cancer Res Ther; 2014; 10(2):284-93. PubMed ID: 25022379
[TBL] [Abstract][Full Text] [Related]
14. Comparison of computed tomography image features extracted by radiomics, self-supervised learning and end-to-end deep learning for outcome prediction of oropharyngeal cancer.
Ma B; Guo J; Chu H; van Dijk LV; van Ooijen PMA; Langendijk JA; Both S; Sijtsema NM
Phys Imaging Radiat Oncol; 2023 Oct; 28():100502. PubMed ID: 38026084
[TBL] [Abstract][Full Text] [Related]
15. Volumetric staging (VS) is superior to TNM and AJCC staging in predicting outcome of head and neck cancer treated with IMRT.
Studer G; Lütolf UM; El-Bassiouni M; Rousson V; Glanzmann C
Acta Oncol; 2007; 46(3):386-94. PubMed ID: 17450476
[TBL] [Abstract][Full Text] [Related]
16. The prognostic role of 18F-fluorodeoxyglucose PET in head and neck cancer depends on HPV status.
Moan JM; Amdal CD; Malinen E; Svestad JG; Bogsrud TV; Dale E
Radiother Oncol; 2019 Nov; 140():54-61. PubMed ID: 31177043
[TBL] [Abstract][Full Text] [Related]
17. Lymph node ratio as a prognostic factor in head and neck cancer patients.
Chen CC; Lin JC; Chen KW
Radiat Oncol; 2015 Aug; 10():181. PubMed ID: 26302761
[TBL] [Abstract][Full Text] [Related]
18. Target volume selection and delineation (T and N) for primary radiation treatment of oral cavity, oropharyngeal, hypopharyngeal and laryngeal squamous cell carcinoma.
Grégoire V; Grau C; Lapeyre M; Maingon P
Oral Oncol; 2018 Dec; 87():131-137. PubMed ID: 30527228
[TBL] [Abstract][Full Text] [Related]
19. CT-based follow-up following radiotherapy or radiochemotherapy for locally advanced head and neck cancer; outcome and development of a prognostic model for regional control.
Nevens D; Vantomme O; Laenen A; Hermans R; Nuyts S
Br J Radiol; 2016 Dec; 89(1068):20160492. PubMed ID: 27710014
[TBL] [Abstract][Full Text] [Related]
20. Analysis of pretreatment FDG-PET SUV parameters in head-and-neck cancer: tumor SUVmean has superior prognostic value.
Higgins KA; Hoang JK; Roach MC; Chino J; Yoo DS; Turkington TG; Brizel DM
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):548-53. PubMed ID: 21277108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
